Leading developer of innovative software solutions that optimize the business performance of life sciences organizations around the world,
DecisionView, Inc. has signed a multi-year agreement with
GlaxoSmithKline (NYSE:
GSK) for the standardization of DecisionView's
StudyManager application for optimizing clinical recruitment performance.
DecisionView's StudyManager 3.2 application is used by clinical teams to optimize clinical recruitment performance in order to reduce recruitment costs and cycle times by automating planning, progress monitoring, predictive modeling and simulation capabilities within the clinical recruitment process.
StudyManager - the industry's first performance optimization solution for clinical trials will be deployed globally by GlaxoSmithKline across all Phase I-IV studies.
Read the full report (a pdf file).
.jpg)
Comment Preview